Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium
Condition(s):Pharmacology, ClinicalLast Updated:August 1, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Pharmacology, ClinicalLast Updated:August 1, 2016Completed
Condition(s):HealthyLast Updated:February 5, 2010Completed
Condition(s):Chronic Plaque-type PsoriasisLast Updated:August 20, 2015Completed
Condition(s):HealthyLast Updated:December 2, 2009Completed
Condition(s):Postoperative Nausea and VomitingLast Updated:August 25, 2020Completed
Condition(s):RosaceaLast Updated:January 9, 2015Completed
Condition(s):Arterial Obstructive DiseasesLast Updated:January 13, 2014Terminated
Condition(s):Seasonal Allergic RhinitisLast Updated:October 4, 2012Completed
Condition(s):Kidney TransplantLast Updated:June 1, 2022Completed
Condition(s):Parkinson’s Disease; PainLast Updated:July 29, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.